Comparison

Hepatitis C Virus NS3 Protease Inhibitor 1 European Partner

Item no. RP11670-5
Manufacturer GenScript
Amount 5.0 mg
Quantity options 1.0 mg 5.0 mg
Category
Type Peptides
Specific against other
Purity > 95%
Sequence Ac-DEMEEC ; {ASP}{GLU}{MET}{GLU}{GLU}{CYS}
ECLASS 10.1 32160409
ECLASS 11.0 32160409
UNSPSC 12352202
Alias peptide/RP11670-Hepatitis_Virus_C_NS3_Protease_Inhibitor_1_Ac-DEMEEC, Hepatitis Virus C NS3 Protease Inhibitor 1 is a potent peptide inhibitor of hepatitis virus C NS3 protease. The hepatitis C virus (HCV) NS3 protease is essential for polyprotein maturation and viral propagation, and it has been proposed as a suitable target for antiviral drug discovery. An N-terminal hexapeptide cleavage product of a dodecapeptide substrate identified as a weak competitive inhibitor of the NS3 protease activity was optimized to a potent and highly specific inhibitor of the enzyme. The effect of this potent NS3 protease inhibitor was evaluated on replication of subgenomic HCV RNA and compared with interferon- (IFN-), which is currently used in the treatment of HCV-infected patients.</td></tr><tr><th>Purity</th><td colspan="7"> > 95% </td></tr><tr><th>Storage</th><td colspan="7"> Store the peptide at -20C. </td></tr>
Similar products Hepatitis
Available
Country of Origin
USA
Storage Conditions
Store the peptide at -20C.
Description
Hepatitis Virus C NS3 Protease Inhibitor 1 is a potent peptide inhibitor of hepatitis virus C NS3 protease. The hepatitis C virus (HCV) NS3 protease is essential for polyprotein maturation and viral propagation, and it has been proposed as a suitable target for antiviral drug discovery. An N-terminal hexapeptide cleavage product of a dodecapeptide substrate identified as a weak competitive inhibitor of the NS3 protease activity was optimized to a potent and highly specific inhibitor of the enzyme. The effect of this potent NS3 protease inhibitor was evaluated on replication of subgenomic HCV RNA and compared with interferon- (IFN-), which is currently used in the treatment of HCV-infected patients.

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 5.0 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close